Pharmacokinetics of Antituberculosis Drugs in Pulmonary Tuberculosis Patients with Type 2 Diabetes

Altered pharmacokinetics of antituberculosis drugs may contribute to an increased risk of tuberculosis treatment failure for diabetic patients. We previously found that rifampin exposure was 2-fold lower in diabetic than in nondiabetic tuberculosis patients during the continuation phase of treatment...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Ruslami, Rovina, Nijland, Hanneke M. J., Adhiarta, I. Gusti N., Kariadi, Sri H. K. S., Alisjahbana, Bachti, Aarnoutse, Rob E., van Crevel, Reinout
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology (ASM) 2010
Onderwerpen:
Pharmacology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2825975/
https://ncbi.nlm.nih.gov/pubmed/20038625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00447-09
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items